Replies to post #396313 on NorthWest Biotherapeutics Inc (NWBO)

[BWIS]

They're probably yet to find a journal wanting to publish their data. So they are telling us that covids slowed and stopped their progress instead of the major journal's indifference.

They've got all their bases covered. They can't tell investors even a tidbit of good news like how many people are still alive or something because, naturally, that would offend RAs.

We all know that RAs are more concerned about their feelings of public pressure than a drugs actual effectiveness.

[sentiment_stocks]

I'm thinking that the fact that the company continued to raise money after June 30, 2021 under the same terms means that they actually did raise money in yet another offering. Do agree, or am I missing something?

During July and August 2021, the Company entered into multiple four-month note agreements (the “Notes”) with various individual lenders (the “Holders”) with an aggregate principal amount of $0.97 million for net proceeds of $0.93 million. The Notes contain a conditional piggy-back right to independently purchase shares from the Company, which provides a right for the Holders, contingent on the release of clinical trial data and the next private placement offering (“Next Offering”) after this release, to (a) purchase shares from the Company within seven days following such Next Offering at a 12% discount from the share price of the Next Offering for a variable number of shares equal to an amount up to 50% of the principal amount of the loan and (b) exchange some or all of the outstanding loan amount for a variable number of shares, within seven days after the Next Offering at a 12% discount, resulting in a reduced cash amount repayable under the loan agreement.